2024
Evaluation of Immunoglobulin A Enzyme Immunoassays to Detect Primary Respiratory Syncytial Virus Infection in Infants and Young Children
Sankaranarayanan R, Ha B, Sun H, Liu K, Jadhao S, Hussaini L, McCracken C, Gibson T, Yildirim I, Yi J, Stephens K, Korski C, Kao C, Rostad C, Anderson E, Anderson L. Evaluation of Immunoglobulin A Enzyme Immunoassays to Detect Primary Respiratory Syncytial Virus Infection in Infants and Young Children. The Journal Of Infectious Diseases 2024, 231: 1060-1068. PMID: 39575588, PMCID: PMC12168064, DOI: 10.1093/infdis/jiae514.Peer-Reviewed Original ResearchRespiratory syncytial virus infectionRespiratory syncytial virusIgA enzyme immunoassayRespiratory syncytial virus seasonDocumented RSV infectionPlasma specimensEnzyme immunoassayRSV infectionRSV-FRespiratory syncytial virus antibodiesGroup DRespiratory syncytial virus FCord blood specimensGroup C specimensAcute lower respiratory infectionGroup B specimensPresence of maternal antibodiesLower respiratory infectionsImmunoglobulin G antibodiesRSV antibodiesNegative control groupSyncytial virusAntibody enzyme immunoassayRespiratory infectionsGroup B
2017
Activity of brigatinib (BRG) in crizotinib (CRZ)-resistant ALK+ NSCLC patients (pts) according to ALK plasma mutation status.
Bazhenova L, Hodgson J, Langer C, Simon G, Gettinger S, Ou S, Reckamp K, West H, Chiappori A, Koh H, Molina J, Shaw A, Patel J, Favaro J, Haney J, Reichmann W, Kerstein D, Rivera V, Camidge D. Activity of brigatinib (BRG) in crizotinib (CRZ)-resistant ALK+ NSCLC patients (pts) according to ALK plasma mutation status. Journal Of Clinical Oncology 2017, 35: 9065-9065. DOI: 10.1200/jco.2017.35.15_suppl.9065.Peer-Reviewed Original ResearchSecondary ALK mutationsNSCLC ptsALK mutationsALK fusionMutation statusObjective response ratePlasma samplesALK mutation statusSelective ALK inhibitorNSCLC patientsClinical activityEvaluable samplesALK inhibitorsResistance patternsSecondary resistanceTherapeutic implicationsComplex mutation patternsResponse rateBrigatinibPlasma specimensWild-type ALKALKTrialsGood responseMutation patterns
2016
Comparison of symmetric dimethylarginine with creatinine, cystatin C and their eGFR equations as markers of kidney function
El-Khoury JM, Bunch DR, Hu B, Payto D, Reineks EZ, Wang S. Comparison of symmetric dimethylarginine with creatinine, cystatin C and their eGFR equations as markers of kidney function. Clinical Biochemistry 2016, 49: 1140-1143. PMID: 27452178, DOI: 10.1016/j.clinbiochem.2016.07.009.Peer-Reviewed Original ResearchConceptsGlomerular filtration rateKidney functionCystatin CEGFR equationsWidespread clinical useIothalamate clearanceEGFR formulasFiltration rateSymmetric dimethylargininePlasma specimensAdult populationStrong markerAbstractTextClinical useEndogenous markerCreatinineLiquid chromatography-tandem mass spectrometry methodChromatography-tandem mass spectrometry methodFurther studiesDimethylarginineRoche Cobas 8000MarkersCatabolic productsCobas 8000
2009
WU Polyomavirus in Patients Infected with HIV or Hepatitis C Virus, Connecticut, USA, 2007 - Volume 15, Number 7—July 2009 - Emerging Infectious Diseases journal - CDC
Miller MA, Weibel C, Ferguson D, Landry ML, Kahn JS. WU Polyomavirus in Patients Infected with HIV or Hepatitis C Virus, Connecticut, USA, 2007 - Volume 15, Number 7—July 2009 - Emerging Infectious Diseases journal - CDC. Emerging Infectious Diseases 2009, 15: 1095-1097. PMID: 19624928, PMCID: PMC2744261, DOI: 10.3201/eid1507.090150.Peer-Reviewed Original ResearchKRAS mutation analysis in cetuximab-treated advanced stage non-small cell lung cancer (NSCLC): SWOG experience with S0342 and S0536
Mack P, Holland W, Redman M, Lara P, Snyder L, Hirsch F, Franklin W, Kim E, Herbst R, Gandara D. KRAS mutation analysis in cetuximab-treated advanced stage non-small cell lung cancer (NSCLC): SWOG experience with S0342 and S0536. Journal Of Clinical Oncology 2009, 27: 8022-8022. DOI: 10.1200/jco.2009.27.15_suppl.8022.Peer-Reviewed Original ResearchNon-small cell lung cancerKRAS mutationsOverall survivalKRAS statusColorectal cancerAdvanced non-small cell lung cancerAdvanced stage non-small cell lung cancerStage non-small cell lung cancerMutant KRASPlasma specimensPredictive roleEGFR tyrosine kinase inhibitorsCetuximab-based therapyProgression-free survivalPhase II trialPhase III trialsWorse overall survivalCell lung cancerKRAS mutation analysisMonoclonal antibody cetuximabTyrosine kinase inhibitorsII trialIII trialsLower eGFRFavorable OS[Evaluation of BED-CEIA assay with dried blood spot specimens in China].
Shen S, Tian F, Jiang HZ, Sun GQ, Miao LF, Guo XL, Xiao Y, Jia YJ, Vermund SH, Jiang Y. [Evaluation of BED-CEIA assay with dried blood spot specimens in China]. Chinese Journal Of Epidemiology 2009, 30: 273-6. PMID: 19642385.Peer-Reviewed Original ResearchConceptsDBS specimensBED-CEIAHIV-1-positive specimensRecent HIV infectionHIV-1 incidencePositive controlHIV infectionHIV incidenceHIV-positiveVoluntary counselingIncidence rateCutoff valueLow positive controlPositive specimensPlasma specimensWindow periodConcordance rateBlood spotsWestern blotEligible pairsFurther studiesNegative controlDBSIncidenceTesting sites
2005
Assessment of a Dietary Questionnaire in Cancer Patients Receiving Cytotoxic Chemotherapy
Meyerhardt JA, Heseltine D, Campos H, Holmes MD, Willett WC, Winer EP, Enzinger PC, Bunnell CA, Kulke MH, Fuchs CS. Assessment of a Dietary Questionnaire in Cancer Patients Receiving Cytotoxic Chemotherapy. Journal Of Clinical Oncology 2005, 23: 8453-8460. PMID: 16293876, DOI: 10.1200/jco.2005.02.5460.Peer-Reviewed Original ResearchMeSH KeywordsAdultAgedAged, 80 and overAntineoplastic AgentsBiomarkersBreast NeoplasmsCarotenoidsColorectal NeoplasmsFatty AcidsFeeding BehaviorFemaleHumansMaleMiddle AgedMultivariate AnalysisNeuroendocrine TumorsNutrition AssessmentNutrition SurveysReproducibility of ResultsSurveys and QuestionnairesTocopherolsConceptsDietary questionnaireCytotoxic chemotherapyCancer patientsPlasma specimensInfluence of dietHealthy populationTotal vitamin E intakeSemiquantitative food frequency questionnaireComprehensive dietary questionnairesFood frequency questionnaireVitamin E intakeBody mass indexTotal energy intakeTotal plasma cholesterolChemotherapy-associated toxicitySelf-reported dietFrequency questionnaireE intakeMass indexSmoking statusNeuroendocrine cancerDietary factorsDietary intakePlasma cholesterolPatients
This site is protected by hCaptcha and its Privacy Policy and Terms of Service apply